# Voxelotor for Improving Oxygen Saturation in Adults

> **NCT05289570** · PHASE2 · TERMINATED · sponsor: **Duke University** · enrollment: 3 (actual)

## Conditions studied

- Acute Lung Injury
- End Stage Lung Disease

## Interventions

- **DRUG:** Voxelotor

## Key facts

- **NCT ID:** NCT05289570
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-03
- **Primary completion:** 2023-06-28
- **Final completion:** 2023-07-04
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Terminated by new sponsor due to funding issues.
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05289570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05289570, "Voxelotor for Improving Oxygen Saturation in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05289570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*